Meron Tibebu

What was reported

$287.89

in general payments reported to CMS, 2019-2025

Who reported paying

General payments only, top 6 by amount.

• Lundbeck LLC $70.46
• Otsuka America Pharmaceutical, INC. $57.82
• Noven Therapeutics, LLC $39.36
• Idorsia Pharmaceuticals US INC $32.10
• Teva Pharmaceuticals USA, INC. $31.10
• Tris Pharma INC $20.91

Drugs and devices associated with these payments

Rexulti Quviviq Austedo Xr Secuado Dyanavel Xr Xelstrym Jornay Pm

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

• I saw Meron Tibebu listed in the CMS Open Payments database. Can you tell me about your work with those companies?
• Is there a generic or alternative to this medication, and would it work as well for me?
• What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.